Wound Closure Market Shifts From Traditional to Advance Products

1 Min Read

As the practice and the market for surgical sealants, glues, wound closure and anti-adhesion evolves, a marked shift is taking place that is moving caseload and market from traditional wound closure products (sutures, staples, mechanical closure, tapes) to advanced wound closure products (hemostats, fibrin and other sealants, high-strength medical adhesives, and post-surgical adhesion prevention).

Below is illustrated the change in the percentage of the total market for wound closure and securement products.

 

As the practice and the market for surgical sealants, glues, wound closure and anti-adhesion evolves, a marked shift is taking place that is moving caseload and market from traditional wound closure products (sutures, staples, mechanical closure, tapes) to advanced wound closure products (hemostats, fibrin and other sealants, high-strength medical adhesives, and post-surgical adhesion prevention).

Below is illustrated the change in the percentage of the total market for wound closure and securement products.

 

Sealants-change-total-market

 

Source: MedMarket Diligence, LLC, Report #S180, “Worldwide Surgical Sealants, Glues, Wound Closure and Anti-Adhesion Markets, 2008-2015″.

Posted via email from medmarket’s posterous

TAGGED:
Share This Article
Follow:
I serve the interests of medical technology company decision-makers, venture-capitalists, and others with interests in medtech producing worldwide analyses of medical technology markets for my audience of mostly medical technology companies (but also rapidly growing audience of biotech, VC, and other healthcare decision-makers). I have a small staff and go to my industry insiders (or find new ones as needed) to produce detailed, reality-grounded analyses of current and potential markets and opportunities. I am principally interested in those core clinical applications served by medical devices, which are expanding to include biomaterials, drug-device hybrids and other non-device technologies either competing head-on with devices or being integrated with devices in product development. The effort and pain of making every analysis global in scope is rewarded by my audience's loyalty, since in the vast majority of cases they too have global scope in their businesses. Specialties: Business analysis through syndicated reports, and select custom engagements, on medical technology applications and markets in general/abdominal/thoracic surgery, interventional cardiology, cardiothoracic surgery, patient monitoring/management, wound management, cell therapy, tissue engineering, gene therapy, nanotechnology, and others.
Exit mobile version